PHE’s Mark Linthicum and Jason Shafrin discuss advancing the science of value assessment and the mission of the Innovation and Value Initiative in the latest edition of Genetic Engineering and Biotechnology News.
PHE Senior Research Economist Jason Shafrin’s latest Op-ed is featured in The Washington Post, as part of their “In Theory” series. The commentary, “How we should pay for cures, according to economics,” examines the current complexities of drug pricing and advocates for value-based pricing structures.
New Office Space at One Grand Central Place Bolsters Square Feet to Nearly 18,000
December 8, 2016 – New York, NY – Precision for Value, the market leader in supporting global pharmaceutical and life sciences companies in achieving commercial excellence, announced the move of its New York City office into a larger location in midtown Manhattan to accommodate rapid growth and an expanding workforce. The office will now be located in One Grand Central Place at 60 East 42nd Street. The nearly 18,000 square foot space will be home to over 80 employees.
PHE Scientific Advisor Anupam Jena was recently featured on the award-winning podcast Freakonomics, as part of their “Bad Medicine: The Story of 98.6” 3-part series. Episode one addresses some of the historical mistakes produced by “trial and error” medicine, and asks whether the new era of evidence-based medicine is the solution. Dr. Jena is featured in the first and third episodes of the series.
PHE Senior Research Economist Jason Shafrin presents an interesting picture of the value and pricing of precision medicine, in a new commentary for MedCity News.
Precision Health Economics founders Darius Lakdawalla and Dana Goldman contribute a new commentary for STAT News: “Election Verdict: Pharma Needs a New Prescription.”
Precision for Value’s Dominic Galante and Maureen Hennessey discuss the subject of patient engagement tools with Keith Loria from Medical Economics, and why more physicians aren’t using them.
Precision Health Economics’ senior research economist Jason Shafrin discusses value-based drug pricing and the benefits for payers in HealthcareDIVE.
Dan Renick, President of global market access specialists Precision for Value, explains “the wedge strategy”in a new article for STAT News.
Deborah Lotterman discusses the challenges translating medical science into communications in STAT News: